Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
TILs（Tumor Infiltrating Lymphocytes）
DRUG
2 trials
Sponsors
Shanghai OriginCell Therapeutics Co., Ltd.
, University Hospital, Basel, Switzerland
Conditions
Carcinoma, Non-Small-Cell Lung
Lung Cancer (NSCLC)
Non-Small Cell Lung Cancer
Early Phase 1
An Exploratory Clinical Study of TILs in the Treatment of Recurrent / Refractory Non-small Cell Lung Cancer (NSCLC)
NCT04919616
Shanghai OriginCell Therapeutics Co., Ltd.
Carcinoma, Non-Small-Cell Lung
Start: 2021-06-15
End: 2025-06-15
Target: 15
Updated: 2021-06-09
Phase 2
TIL Therapy in Non-small-cell Lung Cancer (NSCLC) Patients
Recruiting
NCT06455917
University Hospital, Basel, Switzerland
Lung Cancer (NSCLC), Non-Small Cell Lung Cancer
Start: 2025-01-22
End: 2029-12-31
Target: 30
Updated: 2025-11-19